Dx Deals: Illumina to Acquire SomaLogic from Standard BioTools for $425M
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
The deal is expected to be a big boost for Illumina’s next-generation sequencing platforms
Although briskness in alliances partially offset sluggishness in M&A, October was far less dynamic than September for strategic deal making within the diagnostics sector. Here’s an overview of the key deals that did come down over the 4-week period beginning in late September 2019.
After a brief summer lull, strategic deal making ramped up in September, especially in alliance making where volume nearly doubled last month’s levels. Here’s an overview of the long-term trends and key deals from late August through the third week of September.
From - Laboratory Industry Report
The strategic deal making pot continues to boil, despite the relative inactivity of the established market leaders like Quest, LabCorp and Abbott. Here's a look at…
From - Laboratory Industry Report
The pace of diagnostic deal making picked up from the end of March through mid-April. Here's a quick overview of the activity and…
From - Laboratory Industry Report
The past few weeks have brought snow to parts of the country that don't usually see the white stuff, and a flurry of…